Mcl-1 expression is a predictive marker of response to gemcitabine plus nab-paclitaxel for metastatic pancreatic cancer.
Urabe M, Ikezawa K, Seiki Y, Watsuji K, Kawamoto Y, Hirao T, Kai Y, Takada R, Yamai T, Mukai K, Nakabori T, Uehara H, Nagata S, Ohkawa K.
Urabe M, et al. Among authors: takada r.
Sci Rep. 2024 Sep 20;14(1):21953. doi: 10.1038/s41598-024-73020-8.
Sci Rep. 2024.
PMID: 39304727
Free PMC article.